Literature DB >> 16088464

Zygomycosis.

Alison G Freifeld1, Peter C Iwen.   

Abstract

Zygomycosis is an invasive mycotic disease caused by fungi in the class Zygomycetes. Within this class, the most common species associated with infection include Absidia corymbifera, Apophysomyces elegans, Cunninghamella bertholletiae, Rhizomucor pusillus, Rhizopus microsporus var. rhizopodiformis, and Rhizopus arrhizus. These fungi all produce characteristic hyphal forms in tissue that are variable in width, produce haphazard branching, and lack septation. Although these fungi are ubiquitous in the environment, they are opportunists causing invasive disease in compromised hosts with a high mortality even when aggressive antifungal therapy and surgical intervention are utilized. Clinically, the disease most often affects the sinus with or without pulmonary involvement; direct extension from sinuses into cerebral tissue is not uncommon. This article describes the general clinical features of zygomycosis, with an emphasis on management in the setting of immunosuppression.

Entities:  

Year:  2004        PMID: 16088464     DOI: 10.1055/s-2004-824905

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  6 in total

1.  Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis.

Authors:  Peter C Iwen; Lynne Sigler; Rhonda K Noel; Alison G Freifeld
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

2.  Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia.

Authors:  Peter C Iwen; Alison G Freifeld; Lynne Sigler; Stefano R Tarantolo
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Inhibitory effects of cysteine and cysteine derivatives on germination of sporangiospores and hyphal growth of different Zygomycetes.

Authors:  László Galgóczy; Laura Kovács; Krisztina Krizsán; Tamás Papp; Csaba Vágvölgyi
Journal:  Mycopathologia       Date:  2009-04-19       Impact factor: 2.574

4.  Fulminant Rhizomucor pusillus mucormycosis during anti-leukemic treatment with blinatumomab in a child: A case report and review of the literature.

Authors:  Sarah Schober; Karin Melanie Cabanillas Stanchi; Anna Riecker; Matthias Pfeiffer; Ilias Tsiflikas; Gesa Wiegand; Leticia Quintanilla-Martinez; Susanne Haen; Martin Ebinger; Peter Lang; Rupert Handgretinger; Michaela Döring
Journal:  Med Mycol Case Rep       Date:  2020-12-29

Review 5.  Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.

Authors:  Asim Azhar; Wajihul Hasan Khan; Parvez Anwar Khan; Khaled Alhosaini; Mohammad Owais; Aijaz Ahmad
Journal:  J Infect Public Health       Date:  2022-02-18       Impact factor: 3.718

6.  Rhizomucor pusillus Infection in a Patient with Acute Myeloid Leukaemia After Haematopoietic Stem Cell Transplantation: Clinical Impact of Metagenomics Next-Generation Sequencing.

Authors:  Lilin Liu; Huiqin Wu; Jianghong Liang; Wenhao Wu; Ye Peng; Hua Zhou; Xi Li
Journal:  Infect Drug Resist       Date:  2022-08-06       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.